Humco, a diversified, global pharmaceutical company, announced that their Board of Directors has entered into a definitive merger agreement under which Humco will combine with Fagron, a pharmaceutical company specializing in compounding and personalized medicine, for a value of up to $70 million. Founded in 1872, Humco serves over 45,000 pharmacies and is anchored by its…